Corrigendum to “Arsenic Cardiotoxicity: An Overview” [Environmental Toxicology and Pharmacology 40 (3 (November)) (2015) 1005-1014](S1382668915300727)(10.1016/j.etap.2015.08.030);Arsenic cardiotoxicity: An overview

Environmental Toxicology and Pharmacology

Volumn 40, Issue 3, 2015, Pages 1005-1014

  Alamolhodaei, Nafiseh Sadat ^a   Shirani, Kobra ^a   Karimi, Gholamreza ^b  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Arsenic; Cardiotoxicity; Medicinal plants; QT prolongation

Indexed keywords

ARSENIC; ARSENIC TRIOXIDE; BOERHAAVIA DIFFUSA EXTRACT; CALCIUM CHANNEL L TYPE; CASPASE; CORCHORUS OLITORIUS EXTRACT; ION CHANNEL; MITOGEN ACTIVATED PROTEIN KINASE; PLANT EXTRACT; POTASSIUM CHANNEL; PROTEIN P53; SALVIA MILTIORRHIZA EXTRACT; SILIBUM MARIANUM EXTRACT; TERMINALIA ARJUNA EXTRACT; UNCLASSIFIED DRUG;

ANGINA PECTORIS; ANTIOXIDANT ACTIVITY; APOPTOSIS; BOERHAVIA DIFFUSA; CARDIOMYOPATHY; CARDIOTOXICITY; CHRONICITY; CORCHORUS OLITORIUS; DETOXIFICATION; DNA FRAGMENTATION; ENDOTHELIUM; ENZYME ACTIVATION; EXPOSURE; HEART ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HEART PROTECTION; HUMAN; ISCHEMIC HEART DISEASE; NONHUMAN; OXIDATIVE STRESS; PATHOLOGY; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; QT PROLONGATION; REVIEW; SALVIA MILTIORRHIZA; SIGNAL TRANSDUCTION; SILIBUM MARIANUM; TERMINALIA ARJUNA; TORSADE DES POINTES; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; GENE EXPRESSION REGULATION; MITOCHONDRION;

ANIMALS; APOPTOSIS; ARRHYTHMIAS, CARDIAC; ARSENIC; CARDIOTOXICITY; GENE EXPRESSION REGULATION; HEART FAILURE; HUMANS; MITOCHONDRIA; MYOCARDIAL INFARCTION;

EID: 84947729520     PISSN: 13826689     EISSN: 18727077     Source Type: Journal    
DOI: 10.1016/j.etap.2020.103524     Document Type: Erratum

References (103)

1. Abu-Hadid A.F., El-Shinawy M.Z., El-Bethagy A.S., Gaafer S.A., Medany M. Studies on the production of off-season Jew's mallow (molokhia) in Egypt. Egypt. J. Hortic. 1994, 21:187-193.
2. Agrawal B., Das S., Shukla A.K. Active component from ethanolic extract of Boerhaavia diffusa. Proceedings of the National Conference on Recent Development in Material Science 2011, 82.
3. Alissa E.M., Ferns G.A. Heavy metal poisoning and cardiovascular disease. J. Toxicol. 2011, 2011:870125.
4. Azuma K., Ippoushi K., Ito H., Higashio H., Terao J. Evaluation of antioxidative activity of vegetable extracts in linoleic acid emulsion and phospholipid bilayers. J. Sci. Food Agric. 1999, 79:2010-2016.
5. Azuma K., Nakayama M., Koshioka M., Ippoushi K., Yamaguchi Y., Kohata K., Yamauchi Y., Ito H., Higashio H. Phenolic antioxidants from the leaves of Corchorus olitorius L. J. Agric. Food Chem. 1999, 47:3963-3966.
6. Bosisio E., Benelli C., Pirola O. Effect of the flavanolignans of Silybum marianum L. on lipid peroxidation in rat liver microsomes and freshly isolated hepatocytes. Pharmacol. Res. 1992, 25:147-154.
7. Burtis C.A., Ashwood E.R., Burns D.E., Sawye B.G. Tietz Fundamentals of Clinical Chemistry 2008, 607-608. Saunders Elsevier, The United States. 6th ed.
8. Balakumar P., Kaur J. Arsenic exposure and cardiovascular disorders: an overview. Cardiovasc. Toxicol. 2009, 9:169-176.
9. Banerjee C., Goswami R., Datta S., Rajagopal R., Mazumder S. Arsenic induced alteration in intracellular calcium homeostasis induces head kidney macrophage apoptosis involving the activation of calpain-2 and ERK in Clarias batrachus. Toxicol. Appl. Pharmacol. 2011, 256:44-51.
10. Chambon J.P., Nakayama A., Takamura K., McDougall A., Satoh N. ERK and JNK-signalling regulate gene networks that stimulate metamorphosis and apoptosis in tail tissues of ascidian tadpoles. Development 2007, 134:1203-1219.
11. Chang C.C., Ho S.C., Tsai S.S., Yang C.Y. Ischemic heart disease mortality reduction in an arseniasis-endemic area in southwestern Taiwan after a switch in the tap-water supply system. J. Toxicol. Environ. Health 2004, 67:1353-1361.
12. Chang S.I., Jin B., Youn P., Park C., Park J.D., Ryu D.Y. Arsenic-induced toxicity and the protective role of ascorbic acid in mouse testis. Toxicol. Appl. Pharmacol. 2007, 218:196-203.
13. Chen C.J., Chiou H.Y., Chiang M.H., Lin L.J., Tai T.Y. Dose-response relationship between ischemic heart disease mortality and long-term arsenic exposure. Arterioscler. Thromb. Vasc. Biol. 1996, 16:504-510.
14. Chen Y.C., Lin-Shiau S.Y., Lin J.K. Involvement of reactive oxygen species and caspase 3 activation in arsenite-induced apoptosis. J. Cell. Physiol. 1998, 177:324-333.
15. Chen X., Chen S.H., Zhao J., Hong Y., Bai Y., Sun I., Pan Z., Zhang Y., Yang B., Du Z. L-type calcium current (ICa, L) and inward rectifier potassium current (IK1) are involved in QT prolongation induced by arsenic trioxide in rat. Cell. Physiol. Biochem. 2010, 26:967-974.
16. Chen Y., Graziano J.H., Parvez F., Liu M., Slavkovich V., Kalra T., et al. Arsenic exposure from drinking water and mortality from cardiovascular disease in Bangladesh: prospective cohort study. BMJ 2011, 342.
17. Cheng T.O. Cardiovascular effects of Danshen. Int. J. Cardiol. 2007, 121:9-22.
18. Chu W., Li C., Qu X., Zhao D., Wang X., Yu X., Cai F., Liang H., Zhang Y., Zhao X., Li B., Qiao G., Dong D., Lu Y., Du Z., Yang B. Arsenic-induced interstitial myocardial fibrosis reveals a new insight into drug-induced long QT syndrome. Cardiovasc. Res. 2012, 96:90-98.
19. Das A.K., Sahu R., Dua T.K., Bag S., Gangopadhyay M., Sinha M.K., Dewanjee S. Arsenic-induced myocardial injury: protective role of Corchorus olitorius leaves. Food Chem. Toxicol. 2010, 48:1210-1217.
20. De Groot H., Rauen U. Tissue injury by reactive oxygen species and the protective effects of flavonoids. Fundam. Clin. Pharmacol. 1998, 12:249-255.
21. Dwivedi S. Antianginal and cardioprotective effects of Terminalia arjuna, an indigenous drug, in coronary heart disease. J. Assoc. Physicians India 1994, 42:287-289.
22. Dwivedi S. Terminalia arjuna Wight & Arn. - a useful drug for cardiovascular disorders. J. Ethnopharmacol. 2007, 114:114-129.
23. Edwards D.H., Li Y., Ellinsworth D.C., Griffith T.M. The effect of inorganic arsenic on endothelium-dependent relaxation: role of NADPH oxidase and hydrogen peroxide. Toxicology 2013, 306:50-58.
24. Fan Y., Wang C., Zhang Y., Hang P., Liu Y., Pan Z., Wang N., Du Z. Genistein ameliorates adverse cardiac effects induced by arsenic trioxide through preventing cardiomyocytes apoptosis. Cell. Physiol. Biochem. 2013, 31:80-91.
25. Ferri K.F., Kroemer G. Organelle-specific initiation of cell death pathways. Nat. Cell Biol. 2001, 3:255-263.
26. Ficker E., Kuryshev Y.A., Dennis A.T., Obejero-Paz C., Wang Lu., Hawryluk P., Wible B.A., Brown A.M. Mechanisms of arsenic-induced prolongation of cardiac repolarization. Mol. Pharmacol. 2004, 66:33-44.
27. Ghosh J., Das J., Manna P., Sil P.C. Taurine prevents arsenic-induced cardiac oxidative stress and apoptotic damage: role of NF-κB, p38 and JNK MAPK pathway. Toxicol. Appl. Pharmacol. 2009, 240:73-87.
28. Gowda B.C., Sundharam B.S., Mahadesh J., Mukund Oral-toxicology. J. Forensic Dent. Sci. 2014, 6(1):3.
29. Gunduz O., Bakar C., Simsek C., Baba A., Elci A., Gurleyuk H., et al. Statistical analysis of death causes (2005-2010) in villages of Simav Plain, Turkey, with high arsenic levels in drinking water supplies. Arch. Environ. Occup. Health 2014, 70(1):35-46.
30. Hirano S., Cui X., Li S., Kanno S., Kobayashi Y., Hayakawa T., Shraim A. Difference in uptake and toxicity of trivalent and pentavalent inorganic arsenic in rat heart microvessel endothelial cells. Arch. Toxicol. 2003, 77:305-312.
31. Hoffman R.S., Howland M.A., Lewin N.A., Nelson L.S., Goldfrank L.R. Goldfrank's Toxicologic Emergencies 2015, 2868-2878. McGraw- Hill, The United States. 10th ed.
32. Hong Y.S., Song K.H., Chung J.Y. Health effects of chronic arsenic exposure. J. Prev. Med. Public Health 2014, 47:245.
33. Hopenhayn-Rich C., Browning S.R., Hertz-Picciotto I., Ferreccio C., Peralta C., Gibb H. Chronic arsenic exposure and risk of infant mortality in two areas of Chile. Environ. Health Perspect. 2000, 108:667.
34. Hsieh Y.C., Hsieh F.I., Lien L.M., Chou Y.L., Chiou H.Y., Chen C.J. Risk of carotid atherosclerosis associated with genetic polymorphisms of apolipoprotein E and inflammatory genes among arsenic exposed residents in Taiwan. Toxicol. Appl. Pharmacol. 2008, 227:1-7.
35. Hu P., Luo G.A., Zhao Z., Jiang Z.H. Quality assessment of radix Salviae miltiorrhizae. Chem. Pharm. Bull. 2005, 53:481-486.
36. Ioannou P.V., Vachliotis D.G., Kouli O. The reaction of British Anti-Lewisite (dimercaprol) with As (III), Sb (III), and Bi (III) oxides and salts. Main Group Chem. 2013, 12:235-249.
37. James K.A., Byers T., Hokanson J.E., Meliker J.R., Zerbe G.O., Marshall J.A. Association between lifetime exposure to inorganic arsenic in drinking water and coronary heart disease in Colorado residents. Environ. Health Perspect. 2014, 123:128-134.
38. Jiang R.W., Lau K.M., Hon P.M., Mak T.C.W., Woo K.S., Fung K.P. Chemistry and biological activities of caffeic acid derivatives from Salvia miltiorrhiza. Curr. Med. Chem. 2005, 12:237-246.
39. Jomova K., Valko M. Advances in metal-induced oxidative stress and human disease. Toxicology 2011, 283:65-87.
40. Karthikeyan K., Sarala Bai B.R., Gauthaman K., Sathish K.S., Niranjali Devaraj S. Cardioprotective effect of the alcoholic extract of Terminalia arjuna bark in an in vivo model of myocardial ischemic reperfusion injury. Life Sci. 2003, 73:2727-2739.
41. Katzung B.G., Masters S.B., Trevor A.J. Katzung & Trevor's Pharmacology Examination and Board Review 2012, 1017-1019. McGraw-Hill, The United States. 12th ed.
42. Klaassen C.D. Casarett and Doull's Toxicology: The Basic Science of Poisons 2013, 989. McGraw-Hill, The United States. 8th ed.
43. Kumazaki M., Ando H., Sasaki A., Koshimizu T.A., Ushijima K., Hosohata K., Oshima Y., Fujimura A. Protective effect of α-lipoic acid against arsenic trioxide-induced acute cardiac toxicity in rats. J. Pharmacol. Sci. 2011, 115:244-248.
44. Landrigan P.J. Occupational and community exposures to toxic metals: lead, cadmium mercury and arsenic. West. J. Med. 1982, 137:531-539.
45. Larochette N., Decaudin D., Jacotot E., Brenner C., Marzo I., Susin S.A., Zamzami N., Xie Z., Reed J., Kroemer G. Arsenite induces apoptosis via a direct effect on the mitochondrial permeability transition pore. Exp. Cell Res. 1999, 249:413-421.
46. Lee M.Y., Bae O.N., Chung S.M., Kang K.T., Lee J.Y., Chung J.H. Enhancement of platelet aggregation and thrombus formation by arsenic in drinking water: a contributing factor to cardiovascular disease. Toxicol. Appl. Pharmacol. 2002, 179:83-88.
47. Lee M.Y., Jung B.I., Chung S.M., Bae O.N., Lee J.Y., Park J.D., et al. Arsenic-induced dysfunction in relaxation of blood vessels. Environ. Health Perspect. 2003, 111:513.
48. Li L.N. Biologically active components from traditional Chinese medicines. Pure Appl. Chem. 1998, 70:547-554.
49. Liu J., Zheng B., Aposhian H.V., et al. Chronic arsenic poisoning from burning high-arsenic-containing coal in Guizhou, China. Environ. Health Perspect. 2002, 110:119-122.
50. Manna P., Sinha M., Sil P.C. Arsenic-induced oxidative myocardial injury: protective role of arjunolic acid. Arch. Toxicol. 2008, 82:137-149.
51. Mathews V.V., Paul M.V.S., Abhilash M., Manju A., Abhilash S., Nair R.H. Myocardial toxicity of acute promyelocytic leukaemia drug-arsenic trioxide. Eur. Rev. Med. Pharmacol. Sci. 2013, 17:34-38.
52. Mazumder D.G., Majumdar K.K., Kar-Purkayastha I., Ghose A., Mistry G., Saha C., et al. Ischemic heart disease in chronic arsenic exposure: a case control study in West Bengal. Glob. Adv. Res. J. Med. Med. Sci. 2013, 2:47-54.
53. Medrano M.A.J., Boix R., Pastor-Barriuso R., Palau M., Damián J., Ramis R., et al. Arsenic in public water supplies and cardiovascular mortality in Spain. Environ. Res. 2010, 110:448-454.
54. Miller A.L. Botanical influences on cardiovascular disease. Altern. Med. Rev. 1998, 3:422-431.
55. Mira L., Silva M., Manso C.F. Scavenging of reactive oxygen species by silibinin dihemisuccinate. Biochem. Pharmacol. 1994, 48:753-759.
56. Mittal P., Chhillar D., Dhattarwal S., Singla K., Merry V., Singh S. Criminal arsenic poisoning - a case report. Anil Aggrawal's Internet J. Forensic Med. Toxicol. 2014, 15.
57. Monwarul Islam A.K.M., Majumder A.A.S. Coronary artery disease in Bangladesh: a review. Indian Heart J. 2013, 65(4):424-435.
58. Mumford J.L., Wu K., Xia Y., Kwok R., Yang Z., Foster J., Sanders W.E. Chronic arsenic exposure and cardiac repolarization abnormalities with QT interval prolongation in a population-based study. Environ. Health Perspect. 2007, 115:690-694.
59. Muthumani M., Prabu S.M. Silibinin potentially attenuates arsenic-induced oxidative stress mediated cardiotoxicity and dyslipidemia in rats. Cardiovasc. Toxicol. 2013, 14:83-97.
60. Müzes G., Deák G., Láng I., Nékám K., Gergely P., Fehér J. Effect of the bioflavonoid silymarin on the in vitro activity and expression of superoxide dismutase (SOD) enzyme. Acta physiol. Hung. 1991, 78:3-9.
61. Nordberg G.F., Fowler B.A., Nordberg M. Handbook on the Toxicology of Metals 2014, 314. Academic Press, Elsevier, The United States. 4th ed.
62. Packer L., Rimbach G., Virgili F. Antioxidant activity and biologic properties of a procyanidin-rich extract from pine (Pinus Martima) bark, pycnogeol. Free Radic. Biol. Med. 1999, 27:704-724.
63. Pandey R., Maurya R., Singh G., Sathiamoorthy B., Naik S. Immunosuppressive properties of flavonoids isolated from Boerhaavia diffusa (Linn.). Immunopharmacology 2005, 5:541-553.
64. Park J.H., Kim E.J., Jang H.Y., Shim H., Lee K.K.J.O., Kim H.J., Yang H.J., Jeong S.H., Kim E.T.H.R. Combination treatment with arsenic trioxide and sulindac enhances apoptotic cell death in lung cancer cells via activation of oxidative stress and mitogen-activated protein kinases. Oncol. Rep. 2008, 20:379-438.
65. Pearson G., Robinson F., Beers Gibson T., Xu B.E., Karandikar B.E., Berman M.K., Cobb M.H. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr. Rev. 2001, 22:153-183.
66. Pulido M.D., Parrish A.R. Metal-induced apoptosis: mechanisms. Mutat. Res. 2003, 533:227-241.
67. Raghu K.G., Cherian O.L. Characterization of cytotoxicity induced by arsenic trioxide (a potent anti-APL drug) in rat cardiac myocytes. J. Trace Elem. Med. Biol. 2009, 23:61-68.
68. Raghu K.G., Yadav G.K., Singh R., Prathapan A., Sharma S., Bhadauria S. Evaluation of adverse cardiac effects induced by arsenic trioxide, a potent anti-APL drug. J. Environ. Pathol. Toxicol. Oncol. 2009, 28:241-252.
69. Rahman M.M., Chowdhury U.K., Mukherjee S.C., et al. Chronic arsenic toxicity in Bangladesh and West Bengal, India - a review and commentary. J. Toxicol. Clin. Toxicol. 2001, 39:683-700.
70. Rahman M., Sohel N., Yunus M., Chowdhury M.E., Hore S.K., Zaman K., et al. Increased childhood mortality and arsenic in drinking water in Matlab Bangladesh: a population-based cohort study. PLOS ONE 2013, 8:e55014.
71. Rahnama-Moghadam S., Hillis L.D., Lange R.A. Environmental toxins and the heart. Heart Toxins 2014, 75.
72. Ratnaike R.N. Acute and chronic arsenic toxicity. Postgrad. Med. J. 2003, 79:391-396.
73. Saha J., Dikshit A., Bandyopadhyay M., Saha K. A review of arsenic poisoning and its effects on human health. Crit. Rev. Environ. Sci. Technol. 1999, 29:281-313.
74. Savill J. Apoptosis in resolution of inflammation. Kidney Blood Press. Res. 2000, 23:173-174.
75. Srivastava S., Chen Y., Barchowsky A. Arsenic and cardiovascular disease. Toxicol. Sci. 2009, 107:312-323.
76. Stea F., Bianchi F., Cori L., Sicari R. Cardiovascular effects of arsenic: clinical and epidemiological findings. Environ. Sci. Pollut. Res. 2014, 21:244-251.
77. Sumi D., Sasaki T., Miyataka H., Himeno S. Rat H9c2 cardiac myocytes are sensitive to arsenite due to a modest activation of transcription factor Nrf2. Arch. Toxicol. 2011, 85:1509-1516.
78. Sumitra M., Manikandan P., Kumar D.A., Arutselvan N., Balakrishna K., Manohar B.M., Puvanakrishnan R. Experimental myocardial necrosis in rats: role of arjunolic acid on platelet aggregation, coagulation and antioxidant status. Mol. Cell. Biochem. 2001, 224:135-142.
79. Tripathi Y.B. Terminalia arjuna extract modulates the contraction of rat aorta induced by KCL and nor epinephrine. Phytother. Res. 1993, 7:320-322.
80. Trouillas P., Marsal P., Svobodová A., Vostálová J., Gazák R., Hrbác J., Sedmera P., Kren V., Lazzaroni R., Duroux J.L., Walterová D. Mechanism of the antioxidant action of silybin and 2,3-dehydrosilybin flavonolignans: a joint experimental and theoretical study. J. Phys. Chem. A 2008, 112:1054-1063.
81. Tseng C.H., Chong C.K., Tseng C.P., Hsueh Y.M., Chiou H.Y., Tseng C.C., et al. Long-term arsenic exposure and ischemic heart disease in arseniasis-hyperendemic villages in Taiwan. Toxicol. Lett. 2003, 137:15-21.
82. Tseng C.H. Cardiovascular disease in arsenic-exposed subjects living in the arseniasis-hyperendemic areas in Taiwan. Atherosclerosis 2008, 199:12-18.
83. Tsou T.-C., Tsai F.-Y., Hsieh Y.-W., Li L.-A., Yeh S.C., Chang L.W. Arsenite induces endothelial cytotoxicity by down-regulation of vascular endothelial nitric oxide synthase. Toxicol. Appl. Pharmacol. 2005, 208:277-284.
84. Volkano M., Morris H., Cronin M.T.D. Metals toxicity and oxidative stress. Curr. Med. Chem. 2005, 12:1161-1208.
85. Vineetha V.P., Prathapan A., Soumya R.S., Raghu K.G. Arsenic trioxide toxicity in H9c2 myoblasts - damage to cell organelles and possible amelioration with Boerhavia diffusa. Cardiovasc. Toxicol. 2013, 13:123-137.
86. Velioglu Y.S., Mazza G., Gao L., Oomah B.D. Antioxidant activity and total phenolics in selected fruits, vegetables, and grain products. J. Agric. Food Chem. 1998, 46:4113-4117.
87. Valenzuela A., Bustamante J.C., Videla C., Guerra R. Effect of silybin dihemisuccinate on the ethanol metabolizing systems of the rat liver. Cell Biochem. Funct. 1989, 7:173-178.
88. Wang C.H., Chen C.L., Hsiao C.K., Chiang F.T., Hsu L.I., Chiou H.Y., et al. Increased risk of QT prolongation associated with atherosclerotic diseases in arseniasis-endemic area in southwestern coast of Taiwan. Toxicol. Appl. Pharmacol. 2009, 239:320-324.
89. Wang M., Sun G., Wu P., Chen R., Yao F., Qin M., Luo Y., Sun H., Zhang Q., Dong X., Sun X. Salvianolic acid B prevents arsenic trioxide-induced cardiotoxicity in vivo and enhances its anticancer activity in vitro. Evid. Based Complement. Alternat. Med 2013, 2013:759483.
90. Webster K.A. Mitochondrial membrane permeabilization and cell death during myocardial infarction: roles of calcium and reactive oxygen species. Future Cardiol. 2012, 8:863-884.
91. Weinberg S.L. The electrocardiogram in acute arsenic poisoning. Am. Heart J. 1960, 60(6):971-975.
92. Westervelt P., Brown R.A., Adkins D.R., et al. Sudden death among patients with acute promyelocytic leukemia treated with arsenic trioxide. Blood 2001, 98:266-271.
93. Wu F., Jasmine F., Kibriya M.G., Liu M., Wójcik O., Parvez F., et al. Association between arsenic exposure from drinking water and plasma levels of cardiovascular markers. Am. J. Epidemiol. 2012, 175:1252-1261.
94. Xia Z., Dickens M., Raingeaud J., Davis R.J., Greenberg M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995, 270:1326-1331.
95. Xu L., Deng Y., Feng L., Li D., Chen X., Ma C., Liu X., Yin J., Yang M., Teng F., Wu W., Guan S., Jiang B., Guo D. Cardio-protection of salvianolic acid B through inhibition of apoptosis network. PLoS ONE 2011, 6.
96. Yamanaka K., Okada S. Introduction of lung-specific DNA damage by metabolically methylated arsenic via the production of free radicals. Environ. Health Perspect. 1994, 102:37-40.
97. Yan Y.Y., Wang Y.W., Chen S.L., Zhuang S.R., Wang C.K. Anti-inflammatory effects of phenolic crude extracts from five fractions of Corchorus olitorius L. Food Chem. 2013, 138:1008-1014.
98. Yuan Y., Marshall G., Ferreccio C., Steinmaus C., Selvin S., Liaw J., et al. Acute myocardial infarction mortality in comparison with lung and bladder cancer mortality in arsenic-exposed region II of Chile from 1950 to 2000. Am. J. Epidemiol. 2007, 166:1381-1391.
99. Zhao G.R., Zhang H.M., Ye T.X., Xiang Z.J., Yuan Y.J., Guo Z.X., Zhao L.B. Characterization of the radical scavenging and antioxidant activities of danshensu and salvianolic acid B. Food Chem. Toxicol. 2008, 46:73-81.
100. Zhao X., Feng T., Chen H., Shan H., Zhang Y., Lu Y., Yang B. Arsenic trioxide-induced apoptosis in H9c2 cardiomyocytes: implications in cardiotoxicity. Basic Clin. Pharmacol. Toxicol. 2008, 102:419-425.
101. Zhao X.Y., Li G.Y., Liu Y., Chai L.M., Chen J.X., Zhang Y., Du Z.M., Lu Y.J., Yang B.F. Resveratrol protects against arsenic trioxide induced cardiotoxicity in vitro and in vivo. Br. J. Pharmacol. 2008, 154:105-113.
102. Zhou L., Chow M., Zuo Z. Improved quality control method for Danshen products - consideration of both hydrophilic and lipophilic active components. J. Pharm. Biomed. Anal. 2006, 41:744-750.
103. Zhou L., Zuo Z., Chow M.S. Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J. Clin. Pharmacol. 2005, 45:1345-1359.